SUPERNUS PHARMACEUTICALS INC earnings per share and revenue

S49 earnings per share for the last quarter are 1.05 EUR whereas the estimation was 0.40 EUR which accounts for 163.56% surprise. Company revenue for the same period amounts to 157.79 M EUR despite the estimated figure of 141.32 M EUR. Estimated earnings per share for the next quarter are 0.47 EUR, and revenue is expected to reach 146.74 M EUR. Also watch annual changes over time to get a bigger picture of S49 earnings per share and revenue dynamics.